MAGEA9 and esophageal adenocarcinoma: Overexpression of MAGEA9 correlates with unfavorable survival in lung adenocarcinoma [39], renal cell carcinoma [40], and esophageal adenocarcinomas [41], amongst many other tissues’ cancer.